Stocktoria
Ultragenyx Pharmaceutical Inc. RARE
Ultragenyx Pharmaceutical Inc. institutional holders
| Investor | Shares | Value | % of company |
|---|---|---|---|
| BlackRock Finance, Inc. | 5,603,352 | $230.3M | 5.68% |
| AQR CAPITAL MANAGEMENT LLC | 6,560,809 | $214.1M | 6.65% |
| TWO SIGMA INVESTMENTS, LP | 3,621,200 | $120.9M | 3.67% |
| D. E. Shaw & Co., Inc. | 1,730,193 | $57.8M | 1.75% |
| MILLENNIUM MANAGEMENT LLC | 760,825 | $25.4M | 0.77% |
| RENAISSANCE TECHNOLOGIES LLC | 413,700 | $13.8M | 0.42% |
| CITADEL ADVISORS LLC | 347,631 | $11.6M | 0.35% |
% of company = reported institutional shares ÷ shares outstanding. Based on the latest reports; not every holder reports every quarter.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.